Aaron Cowen’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$326K Hold
17,888
– – 0.01% 87
2026
Q2
$321K Hold
17,888
– – 0.01% 93
2026
Q1
$389K Hold
17,888
– – 0.01% 86
2025
Q4
$385K Hold
17,888
– – 0.01% 90
2025
Q3
$345K Hold
17,888
– – 0.01% 91
2025
Q2
$306K Hold
17,888
– – 0.01% 94
2025
Q1
$1.14M Hold
17,888
– – 0.04% 89
2024
Q4
$2.18M Buy
+17,888
New +$2.19M 0.07% 75
2023
Q4
– Sell
-6,058
Closed -$734K – 97
2023
Q3
$734K Hold
6,058
– – 0.04% 81
2023
Q2
$694K Buy
+6,058
New +$781K 0.04% 92

Other funds holding SRPT

Aaron Cowen's SRPT Position: Q3 2026 in Review

Aaron Cowen held its Sarepta Therapeutics (SRPT) position steady in Q3 2026 at 17,888 shares worth $326K. The position accounts for 0.01% of the portfolio, ranked #87.

Aaron Cowen first reported a position in SRPT in Q2 2023 and has held it in 10 quarters since. The position peaked at $2.18M in Q4 2024. 303 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.

  • Aaron Cowen held 17,888 shares of Sarepta Therapeutics worth $326K as of Q3 2026.
  • Aaron Cowen left its Sarepta Therapeutics share count unchanged in Q3 2026.
  • Sarepta Therapeutics made up 0.01% of Aaron Cowen's portfolio in Q3 2026, its #87 holding.
  • Aaron Cowen first reported a position in Sarepta Therapeutics in Q2 2023 and has held it in 10 quarters since.
  • Aaron Cowen's Sarepta Therapeutics position peaked at $2.18M in Q4 2024.
  • 303 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.

Based on Suvretta Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.